With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Dr. Gabriel Steg introduces a discussion between Drs. Anthony Gershlick and Martial Hamon on achieving a balance between favorable outcomes and reducing bleeding in STEMI patients.
Our international panel of experts, Drs. Hamm, Verheugt, Dauerman, and Rao, give their insights into which antiplatelet and antithrombotic agents they prefer to use and when.
Patients presenting with STEMI represent a high-risk population. Thrombotic and bleeding complications contribute to mortality in these patients. Join Drs. Steg, Hamm, Hill, and Mehran as they discuss best practices for the treatment of STEMI patients with a focus on preventing bleeding complications.
Studies suggest that major bleeding is associated with a 5-fold increase in the risk for death among ACS patients. Join our expert panel: Profs. Hamm, Kristensen, and Spaulding as they discuss treatment options and strategies to reduce bleeding in STEMI patients.
iQandA, The Interactive Medical Intelligence Zone is a needs assessment-driven continuing medical education (CME) activity that utilizes international experts to provide evidence-based, guideline-consistent, and practice behavior-changing information focused on critical and challenging topics in clinical medicine.
New data surrounding the treatment of patients with ACS has led to confusion as to what is the best therapeutic option for a given patient. Join Drs. Sameer Mehta, Michel Le May, Tim Henry, and Michael Mooney as they discuss these data and their applicability to clinical practice.